INSULET CORP 4
4 · INSULET CORP · Filed Mar 6, 2015
Insider Transaction Report
Form 4
INSULET CORPPODD
Diehl R Anthony
Secretary and General Counsel
Transactions
- Sale
Common Stock
2015-03-05$31.50/sh−8,125$255,938→ 48,337 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2015-03-05−1,625→ 3,250 totalExercise: $23.40Exp: 2023-03-01→ Common Stock (1,625 underlying) - Exercise/Conversion
Common Stock
2015-03-05$23.40/sh+1,625$38,025→ 56,462 total
Footnotes (5)
- [F1]Includes 10,000 restricted stock units granted on April 1, 2012 which vest one-half of the total units on April 1, 2015 and one-half of the total units on April 1, 2016; 6,250 restricted stock units granted on March 1, 2013 which vest one-half of the total units on March 1, 2016 and one-half of the total units on March 1, 2017; 4,000 performance share units granted on March 1, 2013, which vest on March 1, 2016; 5,334 restricted stock units granted on March 3, 2014 which vest one-half of the total units on March 3, 2016, and one-half of the total units on March 3, 2017; and 10,253 restricted stock units granted on March 2, 2015, which vest one-third of the total units on March 2, 2016, one-third of the total units on March 2, 2017 and one-third of the total units on March 2, 2018. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date.
- [F2]Includes an aggregate of 1,249 shares acquired under the Insulet Corporation 2007 Employee Stock Purchase Plan on the following dates: 400 shares acquired on December 31, 2007; and 849 shares acquired on June 30, 2008.
- [F3]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 24, 2014.
- [F4]The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $30.79 to $31.89. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full informaiton regarding the number of shares sold at each separate price.
- [F5]This option is subject to a four-year vesting period, with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment.